CD36 and breast cancer: Our results are consistent with those of a recent study reporting a clear segregation of N‐glycans circulating in the blood of patients with BC and normal individuals (Saldova et al., 2014), particularly, for the core fucosylated N‐glycans (Hamfjord et al., 2015; Kizuka and Taniguchi, 2016) that are represented by a set of GP4, GP7, GP10, GP15, GP20, GP23, GP26, GP28, and GP35 structures in our TIF samples.